EODData

NASDAQ, TSHA: Taysha Gene Therapies Inc

25 Sep 26 15:59
LAST:

4.670

CHANGE:
 0.12
OPEN:
4.850
HIGH:
4.880
ASK:
0.000
VOLUME:
2.42M
CHG(%):
2.51
PREV:
4.790
LOW:
4.665
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
25 Sep 264.8804.8804.6654.6704.66M
24 Sep 264.8804.9004.6554.7906.4M
23 Sep 265.1105.1404.8804.9105.51M
22 Sep 265.1105.2155.0825.1602.31M
21 Sep 265.0705.1244.9955.0401.68M
18 Sep 265.1605.2804.9605.0209.12M
17 Sep 265.2505.4605.0505.1604.08M
16 Sep 265.0805.1354.9755.0704.35M
15 Sep 265.0005.1904.9005.0605.15M
14 Sep 265.0005.1204.9805.0106.7M

PROFILE

Name:Taysha Gene Therapies Inc
About:Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. The company has research, collaboration, and license agreement with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.
Sector:Healthcare
Industry:Biotechnology
Address:3000 Pegasus Park Drive, Dallas, TX, United States, 75247
Website:https://www.tayshagtx.com
CUSIP:877619106
CIK:0001806310
ISIN:US8776191061
FIGI:BBG00TJXFDP1

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:2.53 
Forward P/E:-14.97 
PEG Ratio:-11.81 
Price to Sales:167.09 
Price to Book:8.82 
Operating Margin:-13.47 
Return on Assets:-0.21 
Return on Equity:-0.52 
EPS Ratio:-0.38 
Revenue:8.1M 
Shares:287.36M 
Market Cap:1.342B 

TECHNICAL INDICATORS

MA5:4.915.2%
MA10:4.996.8%
MA20:5.2412.3%
MA50:5.7122.2%
MA100:5.9126.6%
MA200:5.4817.2%
RSI14:19.21 
WPR14:-100.00 
MTM14:-0.81
ROC14:-0.15 
ATR:0.24 
Week High:5.2813.1%
Week Low:4.660.3%
Month High:6.2734.3%
Month Low:4.6617.2%
Year High:7.3056.3%
Year Low:3.0453.6%
Volatility:6.72